J Knee Surg 2019; 32(07): 659-666
DOI: 10.1055/s-0038-1666831
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Isolated Tibial Component Failure in Total Knee Arthroplasty: A Case Series Evaluating Inflammatory Response versus Mechanical Failure

Sanar S. Yokhana
1   Department of Orthopaedic Surgery, Detroit Medical Center, Detroit, Michigan
2   Department of Orthopaedic Surgery, Providence-Providence Park Hospital, Southfield, Michigan
,
Christopher Bergum
2   Department of Orthopaedic Surgery, Providence-Providence Park Hospital, Southfield, Michigan
,
Weiping Ren
3   Department of Biomedical Engineering, Wayne State University, Detroit, Michigan
,
David C. Markel
4   Department of Orthopaedic Surgery, St. John-Providence Hospital, Southfield, Michigan
› Author Affiliations
Further Information

Publication History

08 June 2017

26 May 2018

Publication Date:
10 July 2018 (online)

Abstract

Total knee prostheses are routinely redesigned to improve performance, longevity, and to closer mimic the native kinematics of the knee. Despite continued improvements, all knee implants, even those with proven design features, have failures. We identified a cohort of patients with isolated tibial component failures that occurred in a popular and successful knee system. Our purpose was to (1) characterize the observed radiographic failure pattern; (2) investigate the biologic response that may have contributed to the failure; and (3) to determine if the failure mechanism was of a biological or a mechanical nature. Twenty-one knees from 19 patients met the inclusion criteria of isolated tibial component failure in a single knee implant system. Radiographs from the primary and revision knee surgery were analyzed for implant positioning and the failure pattern. Inflammatory biomarkers interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α were available in 16/21 knees and peripheral CD14+/16+ monocytes were measured in 14 of the aforementioned 16 knee revisions. Serum CD3, CD4, and CD19 were measured in 10 of the aforementioned 14 knees. Additionally, white blood cell (WBC) count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) were measured to rule out infection as a cause of the cytokine upregulation. Radiographic findings demonstrated that all of the 21 tibial components were implanted in either neutral or 2 to 3 degrees varus in the coronal plane, and none of the revisions was implanted in valgus. All tibias showed obvious radiographic loosening and the implant failed into varus. The inflammatory biomarkers IL-1β, IL-6, and TNF-α were negative. WBC, ESR, and CRP were normal. Serum CD3, CD4, and CD19 flow cytometry analyses were found to be in the normal range. Peripheral CD14+/16+ and total CD16+ monocytes measurements were consistent with previous findings of patients with osteoarthritis, rather than particulate-induced inflammatory loosening. The findings support the implant failure observed in our study occurred by a different mechanism than the wear debris–induced aseptic loosening. We believe that a mechanical failure can occur based on our findings. The loosening, collapse, and debonding from the cement may have been related to the implantation technique, stresses due to favorable rotational freedoms of the implant, or patient characteristics/behavior. Continued exploration into implant failure mechanisms and particularly into the biologic response associated with failure is ongoing.

 
  • References

  • 1 Callahan CM, Drake BG, Heck DA, Dittus RS. Patient outcomes following tricompartmental total knee replacement. A meta-analysis. JAMA 1994; 271 (17) 1349-1357
  • 2 Dusad A, Pedro S, Mikuls TR. , et al. Impact of total knee arthroplasty as assessed using patient-reported pain and health-related quality of life indices: rheumatoid arthritis versus osteoarthritis. Arthritis Rheumatol 2015; 67 (09) 2503-2511
  • 3 Seo J-G, Moon YW, Cho BC. , et al. Is total knee arthroplasty a viable treatment option in octogenarians with advanced osteoarthritis?. Knee Surg Relat Res 2015; 27 (04) 221-227
  • 4 Stone OD. , et al. Severe arthritis predicts greater improvements in function following total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2017; 25 (08) 2573-2579
  • 5 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
  • 6 Abbas D, Gunn RS. Medium-term results of the Scorpio total knee replacement. Knee 2006; 13 (04) 307-311
  • 7 Borrione F, Bonnevialle P, Mabit C. , et al. Scorpio single radius total knee arthroplasty. A minimal five-year follow-up multicentric study. Int Orthop 2011; 35 (12) 1777-1782
  • 8 Bozic KJ, Kinder J, Meneghini RM, Zurakowski D, Rosenberg AG, Galante JO. Implant survivorship and complication rates after total knee arthroplasty with a third-generation cemented system: 5 to 8 years followup. Clin Orthop Relat Res 2005; (435) 277
  • 9 Colwell Jr CW, Gelber JD, Pulido PA, Casey KM. Early range of motion of the scorpio non-restrictive geometry cruciate-retaining total knee system. J Arthroplasty 2011; 26 (05) 751-755
  • 10 Kolisek FR, Barnes CL. Scorpio posterior-stabilized knee system: 5-year clinical and functional results. J Arthroplasty 2006; 21 (08) 1187-1192
  • 11 Mahoney OM, Kinsey TL. 5- to 9-year survivorship of single-radius, posterior-stabilized TKA. Clin Orthop Relat Res 2008; 466 (02) 436-442
  • 12 Pandit H, van Duren BH, Price M. , et al. Constraints in posterior-stabilised TKA kinematics: a comparison of two generations of an implant. Knee Surg Sports Traumatol Arthrosc 2013; 21 (12) 2800-2809
  • 13 Martin A, Quah C, Syme G, Lammin K, Segaren N, Pickering S. Long term survivorship following Scorpio total knee replacement. Knee 2015; 22 (03) 192-196
  • 14 Silva M, Kabbash CA, Tiberi III JV. , et al. Surface damage on open box posterior-stabilized polyethylene tibial inserts. Clin Orthop Relat Res 2003; (416) 135-144
  • 15 Pajarinen J, Jamsen E, Konttinen YT, Goodman SB. Innate immune reactions in septic and aseptic osteolysis around hip implants. J Long Term Eff Med Implants 2014; 24 (04) 283-296
  • 16 González O, Smith RL, Goodman SB. Effect of size, concentration, surface area, and volume of polymethylmethacrylate particles on human macrophages in vitro. J Biomed Mater Res 1996; 30 (04) 463-473
  • 17 Shanbhag AS, Jacobs JJ, Glant TT, Gilbert JL, Black J, Galante JO. Composition and morphology of wear debris in failed uncemented total hip replacement. J Bone Joint Surg Br 1994; 76 (01) 60-67
  • 18 Abbas S, Clohisy JC, Abu-Amer Y. Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts. J Orthop Res 2003; 21 (06) 1041-1048
  • 19 Gallo J, Kamínek P, Tichá V, Riháková P, Ditmar R. Particle disease. A comprehensive theory of periprosthetic osteolysis: a review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002; 146 (02) 21-28
  • 20 Passlick B, Flieger D, Ziegler-Heitbrock HW. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989; 74 (07) 2527-2534
  • 21 Randolph GJ, Sanchez-Schmitz G, Liebman RM, Schäkel K. The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 2002; 196 (04) 517-527
  • 22 Ren W, Jackson N, Song W, Shi T, Flynn JC, Markel DC. Implant wear induced inflammation is mitigated in CX3CR1(-/-) mice. J Orthop Res 2014; 32 (08) 1037-1043
  • 23 Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM. Effect of anti-tumor necrosis factor-α gene therapy on wear debris-induced osteolysis. J Bone Joint Surg Am 2001; 83-A (12) 1789-1797
  • 24 Ren W, Li XH, Chen BD, Wooley PH. Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-kappaB activity. J Orthop Res 2004; 22 (01) 21-29
  • 25 Ren W, Wu B, Peng X. , et al. Erythromycin inhibits wear debris-induced inflammatory osteolysis in a murine model. J Orthop Res 2006; 24 (02) 280-290
  • 26 Vanlommel J, Luyckx JP, Labey L, Innocenti B, De Corte R, Bellemans J. Cementing the tibial component in total knee arthroplasty: which technique is the best?. J Arthroplasty 2011; 26 (03) 492-496
  • 27 Valiathan R, Deeb K, Diamante M, Ashman M, Sachdeva N, Asthana D. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida. Immunobiology 2014; 219 (07) 487-496
  • 28 Arsoy D, Pagnano MW, Lewallen DG, Hanssen AD, Sierra RJ. Aseptic tibial debonding as a cause of early failure in a modern total knee arthroplasty design. Clin Orthop Relat Res 2013; 471 (01) 94-101
  • 29 Foran JR, Whited BW, Sporer SM. Early aseptic loosening with a precoated low-profile tibial component: a case series. J Arthroplasty 2011; 26 (08) 1445-1450
  • 30 Gandhi R, Santone D, Takahashi M, Dessouki O, Mahomed NN. Inflammatory predictors of ongoing pain 2 years following knee replacement surgery. Knee 2013; 20 (05) 316-318
  • 31 Wu W, Zhang X, Zhang C, Tang T, Ren W, Dai K. Expansion of CD14+CD16+ peripheral monocytes among patients with aseptic loosening. Inflamm Res 2009; 58 (09) 561-570